Related references
Note: Only part of the references are listed.Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Prognostic Role of Squamous Cell Carcinoma Antigen in Cervical Cancer: A Meta-analysis
Zhenhua Liu et al.
DISEASE MARKERS (2019)
The clinical value of PET and PET/CT in the diagnosis and management of suspected cervical cancer recurrence
Ziqi Zhou et al.
NUCLEAR MEDICINE COMMUNICATIONS (2018)
Prognostic Value of Volume-Based Metabolic Parameters of 18F-FDG PET/CT in Uterine Cervical Cancer: A Systematic Review and Meta-Analysis
Sangwon Han et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Clinical Value of Combining F-18-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma
Rajiv Rai Sookha et al.
JOURNAL OF CANCER (2018)
The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma
Yan Wang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)
The Volume-metabolic Combined Parameters from 18F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma
Yanqin Sun et al.
ACADEMIC RADIOLOGY (2016)
Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence
Michela Salvatici et al.
GYNECOLOGIC ONCOLOGY (2016)
Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer
Tasmiah Rahman et al.
MEDICINE (2016)
Factors involved in the delay of treatment initiation for cervical cancer patients A nationwide population-based study
Szu-Ching Shen et al.
MEDICINE (2016)
A Clinicopathological Review of Pulmonary Metastasis from Uterine Cervical Cancer
Eun Young Ki et al.
CANCER RESEARCH AND TREATMENT (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer
Maura Micco et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Prospective evaluation of qualitative and quantitative 18F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix
Sagar Maharjan et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Positron emission tomography scan for predicting clinical outcome of patients with recurrent cervical carcinoma following radiation therapy
Daya Nand Sharma et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
Hyun Hoon Chung et al.
GYNECOLOGIC ONCOLOGY (2011)
The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix
Keiichiro Nakamura et al.
GYNECOLOGIC ONCOLOGY (2010)
Long-term follow up of cervical cancer patients with unexplained squamous cell carcinoma antigen elevation after post-therapy surveillance using positron emission tomography
Mei-Shan Jao et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2010)
The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
Elizabeth A. Kidd et al.
CANCER (2007)
FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value
H Sakurai et al.
GYNECOLOGIC ONCOLOGY (2006)
Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer
N Reesink-Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pulmonary metastases from uterine malignancies: Results of surgical resection in 133 patients
M Anraku et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Recurrent squamous cell carcinoma of cervix after definitive radiotherapy
JH Hong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer
TC Yen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The role of PET scanning in the detection of recurrent cervical cancer
LJ Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2003)
An appraisal of 18F-FDG PET imaging in post-therapy surveillance of uterine cancers: Clinical evidence and a research proposal
T Belhocine
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer
MD Esajas et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
PW Grigsby et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Posttherapy surveillance of women with cervical cancer: An outcomes analysis
D Bodurka-Bevers et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
